A trial of sorafenib in combination with 2 other treatments for liver cancer (SORAMIC)

This trial is looking at a drug called sorafenib in combination with selective internal radiation therapy or radiofrequency ablation to treat liver cancer. The trial is open to people with a type of liver cancer called hepatocellular carcinoma (HCC) that can’t be removed by surgery. This is an international trial and in the UK treatment will be either sorafenib in combination with selective internal radiation therapy (SIRT) or sorafenib alone.